Head-to-Head

Eli Lilly & Co. vs. Prelude Therapeutics Incorporated

LLY

Eli Lilly & Co.

$1157.08 -2.33%

VS PRLD

Prelude Therapeutics Incorporated

$4.87 +6.56%

Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 8 compared factors.

Size & Scale

LLYPRLD
Market Cap $1.06 trillion $388.64 million
Revenue (TTM) $79.67 billion $22.42 million
Net Income (TTM) $26.71 billion $-60,488,000

LLY leads on 3 of 3 size & scale factors.

Valuation

LLYPRLD
P/E Ratio 38.84 —
Price / Book 31.17 2.91
Price / Sales 13.25 17.33

LLY and PRLD split the valuation factors evenly.

Profitability

LLYPRLD
Net Margin 33.53% -269.75%
Return on Equity 78.84% -45.23%

LLY leads on 2 of 2 profitability factors.

Dividend

LLYPRLD
Dividend Yield 0.60% —
Payout Ratio 23.23 —

LLY and PRLD split the dividend factors evenly.

Risk & Sentiment

LLYPRLD
Short Interest 1.29% 0.01%

PRLD leads on 1 of 1 risk & sentiment factors.

Dig deeper: LLY overview, LLY financials, PRLD overview, PRLD financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.